Sigilon Therapeutics Inc Ordinary Shares (NASDAQ:SGTX)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - SGTX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - SGTX

  • Market Cap$1.092bn
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS82657L1070

Company Profile

Sigilon Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is developing a new class of therapeutics and functional cures for patients with chronic diseases by providing stable and durable levels of therapeutic molecules to patients. It's lead product candidate, SIG-001, prevents bleeding in patients with moderate-severe to severe Hemophilia A.

Latest SGTX news

Currently there for this company. Visit our news hub for other news .